Cullinan Oncology
CGEM
CGEM
113 hedge funds and large institutions have $671M invested in Cullinan Oncology in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
40
Reduced
38
Closed
18
Calls
$215K
Puts
$158K
Net Calls
+$57K
Net Calls Change
+$70K
Top Buyers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$23M |
| 2 |
DM
Deerfield Management
New York
|
+$19.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.7M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$11.9M |
Top Sellers
| 1 |
AIG
American International Group
New York
|
-$20.9M |
| 2 |
Morgan Stanley
New York
|
-$11.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$9.96M |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
-$8.43M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$5.99M |
